Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Radiomics and Machine Learning in Medical Imaging, and Pancreatitis Pathology and Treatment.
Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma
DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma
Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy
Blood biomarkers for differential diagnosis and early detection of pancreatic cancer
Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer
MicroRNAs in blood act as biomarkers of colorectal cancer and indicate potential therapeutic targets
<scp>BiasCorrector</scp>: Fast and accurate correction of all types of experimental biases in quantitative <scp>DNA</scp> methylation data derived by different technologies
<i>SST</i> gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis
Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach
NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice
Abstract 4162: The identification of biomarker for the early diagnosis of IPMN associated PDAC based on serum protein profiling
The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation
In situ, Cell-free Protein Expression on Microarrays and Their Use for the Detection of Immune Responses
Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression
Antimicrobial Peptide Human Neutrophil Peptide 1 as a Potential Link Between Chronic Inflammation and Ductal Adenocarcinoma of the Pancreas
Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure
Tumor cells interact with red blood cells via galectin-4 - a short report
Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer
Abstract 1135: DRD2 is critical for pancreatic cancer and promises pharmacological therapy by already established antagonists
Abstract 5925: Mapping the molecular communication within the tumor microenvironment of pancreatic cancer as well as between tumor and peritumoral tissue
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression
<i>GHSR</i> DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers
Transcriptional co‐factor Transducin beta‐like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy
Stratification of pancreatic tissue samples for molecular studies: RNA-based cellular annotation procedure
Abstract 2718: Genomic and microRNAome subtraction identifies pathogenic viral sequences in pancreatic ductal adenocarcinoma
miRNAs can be generally associated with human pathologies as exemplified for miR-144*
Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: An experimental microarray study
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients